Clinical Trial Update: Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bacteriophage therapy for diabetic foot osteomyelitis sponsored by Adaptive Phage Therapeutics has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Osteomyelitis
• Osteomyelitis

Drugs mentioned

• Bacteriophage therapy

Snippet

Sponsor: Adaptive Phage Therapeutics, Inc. | Conditions: Osteomyelitis, Diabetic Foot Osteomyelitis | Phase 2 | Status: TERMINATED